Navigating adjuvant therapy options in hepatocellular carcinoma

Adjuvant Therapy News

Navigating adjuvant therapy options in hepatocellular carcinoma
CarcinomaHepatocellular CarcinomaCancer
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 81 sec. here
  • 15 min. at publisher
  • 📊 Quality Score:
  • News: 78%
  • Publisher: 71%

Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and is the third leading cause of cancer-related deaths.

Xia & He Publishing Inc.Jul 16 2024 Hepatocellular carcinoma is one of the most prevalent malignancies globally and is the third leading cause of cancer-related deaths. The primary curative treatments for HCC are liver transplantation , hepatectomy, and local ablation. However, the recurrence rate of HCC following hepatectomy or ablation remains alarmingly high, up to 70%, severely impacting patient prognosis and overall survival .

HCC recurrence can generally be classified into two categories: early recurrence, which typically occurs within two years post-treatment, and late recurrence, which occurs after two years. Early recurrence is often linked to intrahepatic micrometastases or microthrombi from the primary tumor, whereas late recurrence is usually associated with multicentric new tumor formations.

The primary aim of adjuvant therapy following local treatments like hepatectomy or ablation is to reduce the recurrence rate and thus improve recurrence-free survival and OS. The choice of adjuvant therapy should be guided by the risk factors specific to early or late recurrence. Related StoriesDespite the promising results of various adjuvant therapies, there remain several unanswered questions and challenges. The lack of a universally accepted standard for adjuvant therapy in HCC highlights the need for further research and clinical trials to establish clear guidelines. Moreover, the balance between the benefits and potential adverse effects of adjuvant treatments must be carefully considered to optimize patient outcomes.

In conclusion, while significant strides have been made in the development of adjuvant therapies for HCC, ongoing research and international collaboration are essential to standardize treatment protocols and improve the prognosis for HCC patients worldwide.Journal reference:Li, L., et al. . Adjuvant Therapy for Hepatocellular Carcinoma After Curative Treatment: Several Unanswered Questions. Journal of Clinical and Translational Hepatology. doi.org/10.14218/JCTH.2024.00030.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NewsMedical /  🏆 19. in UK

Carcinoma Hepatocellular Carcinoma Cancer Efficacy Hepatitis Hepatology Interferon Liver Liver Transplantation Research Tenofovir Tumor

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Improving the conversion success rate of hepatocellular carcinomaImproving the conversion success rate of hepatocellular carcinomaHepatocellular carcinoma (HCC) presents significant challenges due to its high incidence and mortality rates, particularly in China where most patients are diagnosed at intermediate or advanced stages. This limits the applicability of curative surgical treatments to only 30% of cases, resulting in a five-year survival rate of 14.2%.
Read more »

Study reveals CREB3's role in hepatocellular carcinoma suppression via AKT signalingStudy reveals CREB3's role in hepatocellular carcinoma suppression via AKT signalingNew research indicates the inhibitory effects of cAMP responsive element binding protein 3 (CREB3) on hepatocellular carcinoma (HCC) in vitro and in vivo. The paper is published in the journal MedComm.
Read more »

Ultrasound techniques for the surveillance, diagnosis, and treatment of hepatocellular carcinomaUltrasound techniques for the surveillance, diagnosis, and treatment of hepatocellular carcinomaHepatocellular carcinoma (HCC) is a primary malignancy of the liver and one of the leading causes of cancer-related deaths worldwide. Early detection and accurate diagnosis are crucial for effective management and improved survival rates.
Read more »

Role of fibrinogen-like protein 1 in tumor recurrence following hepatectomyRole of fibrinogen-like protein 1 in tumor recurrence following hepatectomyHepatocellular carcinoma (HCC), a leading cause of cancer-related mortality globally, exhibits a dismal five-year survival rate of only 18%. Major contributing factors to HCC include viral hepatitis infections and nonalcoholic fatty liver disease.
Read more »

Camila Cabello details 'risky' rebrand while navigating from her transition from 'girlhood into...Camila Cabello details 'risky' rebrand while navigating from her transition from 'girlhood into...Camila Cabello uses a video camera to film herself in a mirror in a video posted onto her Instagram account. The stunning singer dons a sultry plunging sheer black top and black bra underneath.
Read more »

Camila Cabello details 'risky' rebrand while navigating from her transition from 'girlhood into...Camila Cabello details 'risky' rebrand while navigating from her transition from 'girlhood into...Camila Cabello uses a video camera to film herself in a mirror in a video posted onto her Instagram account. The stunning singer dons a sultry plunging sheer black top and black bra underneath.
Read more »



Render Time: 2025-02-14 21:34:54